FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

24 results

avastin
(bevacizumab)
Genentech, Inc.
Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.
aveed
(testosterone undecanoate)
ENDO USA, Inc.
Usage: AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.
bijuva
(estradiol and progesterone)
Mayne Pharma LLC
Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
edex
(alprostadil)
ENDO USA, Inc.
Usage: Edex® is indicated for treating erectile dysfunction stemming from various causes, including neurogenic, vasculogenic, psychogenic, or mixed origins.
evamist
(Estradiol)
Padagis US LLC
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
imvexxy
(estradiol)
Mayne Pharma LLC
Usage: This drug is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy resulting from menopause.
intrarosa
(Prasterone)
Millicent US, Inc.
Usage: INTRAROSA® is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy due to menopause.
jemperli
(dostarlimab)
GlaxoSmithKline LLC
Usage: JEMPERLI is indicated for adults with primary advanced or recurrent endometrial cancer (EC) in combination with carboplatin and paclitaxel, followed by JEMPERLI alone. It also treats adults with mismatch repair deficient recurrent or advanced solid tumors that have progressed after prior treatment and lack satisfactory alternatives.
kyleena
(Levonorgestrel)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.
liletta
(Levonorgestrel)
Allergan, Inc.
Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.

Sexual & Reproductive Health drugs

avastin

aveed

bijuva

edex

evamist

imvexxy

intrarosa

jemperli

kyleena

liletta